ArticleRSC advances2025
Phytochemical-assisted synthesis, optimization, and characterization of silver nanoparticles for antimicrobial activity.
Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Silver Nanoparticles fromACS omega · 2026Article
- Silver-based N-heterocyclic carbene (NHC) complexes as emerging strategies against antimicrobial resistance.Archives of microbiology · 2026Review
- Eco-friendly flower-like ZnO nanostructures for photocatalytic treatment of levofloxacin-contaminated wastewater.Scientific reports · 2026Article
- Ecofriendly synthesis of silver nanoparticles using Barleria gibsonii and evaluation of antibacterial antioxidant cytotoxic and catalytic activities.Scientific reports · 2026Article
- Eco-friendly silver nanoparticles from neem extracts: a dual approach to heavy metal sensing and antimicrobial applications.Bioresources and bioprocessing · 2026Article
- Antibacterial, antibiofilm and cytotoxic properties of Aloe vera-synthesized silver titanium nanoparticles.AMB Express · 2025Article
- The Antimicrobial Activity of Silver Nanoparticles Biosynthesized UsingPharmaceuticals (Basel, Switzerland) · 2025Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The increasing prevalence of antimicrobial resistance (AMR) bacteria poses a major global health threat, compounded by the limited development of new antibiotics. To address this challenge, alternative strategies, including nanoparticle-based therapies, are being explored. This study investigates the antimicrobial properties of green-synthesized silver nanoparticles (AgNPs) derived from leaf extracts of
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.